A startup looking to reverse type 1 diabetes just raised $114 million
|11/30/2017||Posted by BusinessMediaguide.Com under General World News||
- Semma Therapeutics, a startup developing treatments with an aim to cure type 1 diabetes, just raised $114 million.
- It is using stem cells to make beta cells, which are key to regulating blood sugar in the body. In people living with type 1 diabetes, the body has destroyed these cells.
- If it works, it could lead to other regenerative medicine treatments.
A startup that wants to change the way we treat type 1 diabetes just raised $114 million.
Semma Therapeutics, a company that got its start in 2014, is researching ways to use stem cells that act like key cells read more >>>